- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Canon Medical Systems Unveils CXDI-Elite Digital Radiography Products
The new digital radiography series reportedly offers proprietary technologies that can preserve image quality and allow better control of X-ray dosage.
Emphasizing ease of use, optimal image quality and reduced radiation dose, Canon Medical Systems has launched the CXDI-Elite digital radiography series.
The CXDI-Elite series offers an array of benefits, including the company’s image processing technology Intelligent NR, which reduces graininess and unnecessary noise while preserving optimal strength of signal, according to Canon Medical Systems.
The company added that the CXDI-Elite series will include Built-in AEC Assistance, a proprietary technology that enables real-time assessment of corresponding pixel value to emitted X-rays through the device’s image sensor. Canon Medical Systems said this information enables radiologists to have improved control over the X-ray dosage.
Canon Medical Systems noted that the CXDI-Elite series also includes the new CXDI-720C Wireless sensor unit, which provides enhanced functionality and support for radiation dose control while ensuring high image quality and sensitivity.
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
April 22nd 2024In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Interventional Radiology Study Shows Low Breast Cancer Recurrence 16 Months After Cryoablation
March 29th 2024In a cohort of patients with invasive breast cancer and tumor sizes ranging between 0.3 to 9 cm, image-guided cryoablation was associated with a 10 percent recurrence rate at 16 months, according to research recently presented at the Society of Interventional Radiology (SIR) conference.
